DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2004/0260188A1 Syed Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2004/0260188A1 Syed Et Al US 2004O26O188A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0260188A1 Syed et al. (43) Pub. Date: Dec. 23, 2004 (54) AUTOMATED AUSCULTATION SYSTEM The present invention provides Systems and methods for performing automated auscultation and diagnosis of condi (75) Inventors: Zeeshan Hassan Syed, Wayzata, MN tions of the cardiovascular System. The invention acquires (US); John Guttag, Lexington, MA an acoustic Signal emanating from the cardiovascular System (US); Robert A. Levine, Brookline, MA (US); Francesca Nesta, Boston, via an Sensor. In addition, in certain embodiments of the MA (US); Dorothy Curtis, invention an electrical Signal, e.g., an electrocardiogram Framingham, MA (US) (EKG) is simultaneously acquired. The signals are digitized, and, optionally, filtered to remove noise. The invention then Correspondence Address: processes and analyses the signal(s) So as to provide a Choate, Hall & Stewart clinically relevant conclusion or recommendation Such as a Exchange Place diagnosis or Suggested additional tests or therapy. In pre 53 State Street ferred embodiments the System comprises: (1) a beat Selec Boston, MA 02109 (US) tion component that Selects a plurality of beats for analysis, (73) Assignees: The General Hospital Corporation; wherein each beat comprises an acoustic Signal emanating Massachusetts Institute of Technology from the cardiovascular System; (2) a time-frequency analy sis component that performs a time-frequency decomposi (21) Appl. No.: 10/464,267 tion of beats Selected for analysis So as to identify or extract physiologically relevant features; and (3) a processing com (22) Filed: Jun. 17, 2003 ponent that processes the information So at to provide a clinically relevant conclusion or recommendation. In pre Publication Classification ferred embodiments of the invention the system further includes an aggregation component that combines informa (51) Int. Cl." ....................................................... A61B 5/04 tion obtained from a plurality of the beats selected for (52) U.S. Cl. ........................... 600/509; 600/513; 600/528 analysis. In one embodiment, the System diagnoses mitral (57) ABSTRACT Valve prolapse. Phonocardiogram Electrocardiogram P Q S Ventricular systole Reproduced from http://meds.queensu.ca/medicine/physiol/undergrad/phase2/Lecture5f. ppt Patent Application Publication Dec. 23, 2004 Sheet 1 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 2 of 41 US 2004/0260188A1 Z'5DI Patent Application Publication Dec. 23, 2004 Sheet 3 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 4 of 41 US 2004/0260188A1 QRS wave Reproduced from http://faculty.ucc.edu/biologypotter/Heart Physiology/sld011.htm FIG. 4 S1 I S2 S1 S2 O .2 .4 .6 8 1. O 1.2 1.4 1.6 Time-SeC. Reproduced from http://meds, queensu.ca/medicine/physiol/undergrad/phase2/Lecture5f. ppt FIG. 5 Patent Application Publication Dec. 23, 2004 Sheet 5 of 41 US 2004/0260188A1 Phonocardiogram Electrocardiogram Q S Ventricular systole Reproduced from http://meds.queensu.ca/medicine/physiol/undergrad/phase2/Lecture5f. ppt FIG. 6 AOrtic area Pulmonic area (2nd-3rd right (2nd-3rd left interspace) interspace) Tricuspid area Mitral area (Left lower sternal (apex) border) Reproduced from http://meds.cqueensu.ca/medicine/physiol/undergrad/phase2/Lecture5f. ppt FIG. 7 Patent Application Publication Dec. 23, 2004 Sheet 6 of 41 US 2004/0260188A1 Early Systolic Murmur - begins with S1 and ends before or about the middle of systole. Mid Systolic Murmur - begins after S1 and ends before S2. Late Systolic Murmur - begins at about the middle of systole and ends at the time of S2. Holosystolic Murmur - begins with S1 and ends with, or continues somewhat beyond, S2. Early Diastolic Murmur - begins with S2. Mid Diastolic Murmur - begins after S2. Late Diastolic Murmur - begins immediately prior Continuous Murmur - has both systolic and diastolic components. Crescendo - the loudness of the murmur increases progressively. The systolic Component of a patent ductus areriosus murmur is of this type. DeCrescendo - the loudness of the murmur decreases progressively. The murmurs of aortic and pulmonic regurgitation are examples of this type. |Crescendo-Decrescendo - the loudness of the murmur increases and then decreases. This configuration is typical of systolic ejection murmurs. Plateau - the loudness of the murmur remains relatively constant. Holosystolic murmurs are representative of this type. Reproduced from http://www.nurspeak.com/tools/docs/murmur patterns.doc FIG. 8 Patent Application Publication Dec. 23, 2004 Sheet 7 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 8 of 41 US 2004/0260188A1 II'5DI Patent Application Publication Dec. 23, 2004 Sheet 9 of 41 US 2004/0260188A1 OY Patent Application Publication Dec. 23, 2004 Sheet 10 of 41 US 2004/0260188A1 9.I"5DI ZHOOI-GºI Patent Application Publication Dec. 23, 2004 Sheet 11 of 41 US 2004/0260188A1 #7I"5ÐI Patent Application Publication Dec. 23, 2004 Sheet 12 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 13 of 41 US 2004/0260188A1 10K O. 5X 19 5 350-4OO HZ 400-450 H -5 -5 O x 103 48 103 2. SOO-550 HZ O -2 2 x 103 1. 600-650 HZ O -1 4. x 103 2. 700-750 HZ O -2 2 x 103 2 x 103 800-850 HZ O.25 0.5 X-axis: Time (s), Y-axis: Amplitude FIG. 16 Patent Application Publication Dec. 23, 2004 Sheet 14 of 41 US 2004/0260188A1 O co 15O-2OO HZ y V 600-650 Hz 800-850 HZ O 0.25 O.5 O 0.25 O.5 IX-axis: Time (s), Y-axis: Amplitude FIG. 17 Patent Application Publication Dec. 23, 2004 Sheet 15 of 41 US 2004/0260188A1 all-e-w- 150-200 HZ O 250-3OO HZ O O 350-400 HZ 400-450 Hz 450-500 HZ O O 550-600 HZ 600-650 Hz O O -----650-700 HZ ow---750-800 Hz 800-850 Hz O O.25 O. 5 O O.25 O 5 X-axis: Time (s), Y-axis: Amplitude FIG. 18 Patent Application Publication Dec. 23, 2004 Sheet 16 of 41 US 2004/0260188A1 O O.25 O.5 O O.25 0.5 IX-axis: Time (s), Y-axis: Amplitude FIG. 19 Patent Application Publication Dec. 23, 2004 Sheet 18 of 41 US 2004/0260188A1 IZ'5DI Patent Application Publication Dec. 23, 2004 Sheet 19 of 41 US 2004/0260188A1 "00OGZ0S’ Patent Application Publication Dec. 23, 2004 Sheet 20 of 41 US 2004/0260188A1 ZHOGS-OGE Patent Application Publication Dec. 23, 2004 Sheet 21 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 24 of 41 US 2004/0260188A1 ZHOSG-099) ZH098-0SS Patent Application Publication Dec. 23, 2004 Sheet 25 of 41 US 2004/0260188A1 ZHOSI-09 Patent Application Publication Dec. 23, 2004 Sheet 26 of 41 US 2004/0260188A1 ~~ ZH09T-09 ZHOS8-09I ZH098-099 Patent Application Publication Dec. 23, 2004 Sheet 27 of 41 US 2004/0260188A1 ~~~~); ZH098–09G 09."5DI Patent Application Publication Dec. 23, 2004 Sheet 28 of 41 US 2004/0260188A1 ZH09T-09 IS’5ÐI Patent Application Publication Dec. 23, 2004 Sheet 29 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 30 of 41 US 2004/0260188A1 ZH098-099 99"5ÐI Patent Application Publication Dec. 23, 2004 Sheet 31 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 32 of 41 US 2004/0260188A1 ZH098.-09.I ZHOSG-099) ZH098-099 Patent Application Publication Dec. 23, 2004 Sheet 33 of 41 US 2004/0260188A1 ZHOST-OS 99'5DI Patent Application Publication Dec. 23, 2004 Sheet 34 of 41 US 2004/0260188A1 Patent Application Publication Dec. 23, 2004 Sheet 35 of 41 US 2004/0260188A1 ZH09T-09 89"5DI (N O CO. VO V (n O ?y) in H O n c O Patent Application Publication Dec. 23, 2004 Sheet 36 of 41 US 2004/0260188A1 1OO 90 -------------------- - - - - - - - - - - - - - - - - - - - . a- - - - - - - - OurPrimary System Care Physicians 8O - - - - - - - - - - - - - - - - row - - - - - - - rew sw----------- as aws 8-ass wwrew sess ---- ww.-- Y--www.rwarra rew wrvo v Karss r^**** ******** 5 70 -rror. 60 -- - - - - - - - - - - - - - - - - - - a a a a - - immor E. 50 C 8 40 . - - - - - - - - - - - - - - - - - mem 3O -. "N- - - - - - - - - - - - - - - - - - - - - - 2O -. - - - - - - - - - - - - - - - - - - - - - - - - - -- a-a- - - - - - - - a - - - - - - - - - - - - g a a a man a 2 . - - - - - - - False POSitives False Negatives FIG. 39 129/o False POsitive False Negative 109/ "Z ---- - - - - - - - - - 2 - - - - - - - - - - - - - - - - - - - - 2 A A 2 - - - - - - Z w w w w - - - - - - - - s s - s s s s i,5 80/"Z 3 a a - a - 1 - Z3 a - 1 - 1 m -- a %.3 32 - 3% - - - - - - a a a -aa a - - - - - - is 2 333%% %2%,2 3323 2 %2. 4%-22 %2 2%2%% % % % 29/6 % a a a m % a ma a % % % AAA % -- O9/ 3%.% 2 3%.% 3%32 2 % -209/6 -1096 -596 O96 --596 - 1096 +20% Percentage Change in Value FIG. 40 Patent Application Publication Dec. 23, 2004 Sheet 37 of 41 US 2004/0260188A1 1296 False Positives O False Negatives 10% -rr • * * * * * Zr ----------- Zr --------- - - - - Zr 3 %, 3 %, 3 %, 3 E 6%-3-2-32 %, 3, 2,%, 3,3%. 3 &2 S 4% - %.2 A A %3%. A % - - - - - 2,% %21 %2 %3 23|" || 2 || 23 |||| 3 || 23 |||| 33 |||| 32 ||| 32 | %2%2, 3, 2, 23, 2,% 231, 2% O -200/6 -100/6 -59/6 O/6 --596 - 100/6 -200/6 Percentage Change in Value FIG. 41 259/6 2 ZZ False POSitives 5 zo. %3 , ERR. 515%is - &3 32 "210% % V X X % A A w. A A A 2% 59 3,% 2% - A 3% O96 % % % -20% -10% -5% 0% " +5% +10% +20% Percentage Change in Value FIG 42 Patent Application Publication Dec. 23, 2004 Sheet 38 of 41 US 2004/0260188A1 ZH099-09I ZH09G-0G9 | Patent Application Publication Dec. 23, 2004 Sheet 39 of 41 US 2004/0260188A1 VO O Ln O V O zHOSS-ôse Z'0 ~~);0 Patent Application Publication Dec.
Load more

Recommended publications
  • A Case Report of Takotsubo Syndrome Complicated by Ischaemic Stroke: the Clinical Dilemma of Anticoagulation
    European Heart Journal - Case Reports CASE REPORT doi:10.1093/ehjcr/ytab051 Other A case report of takotsubo syndrome complicated by ischaemic stroke: the clinical dilemma of anticoagulation Giuseppe Iuliano 1, Rosa Napoletano2, Carmine Vecchione 1,3, and Downloaded from https://academic.oup.com/ehjcr/article/5/3/ytab051/6170700 by guest on 01 October 2021 Rodolfo Citro 1* 1Cardiothoracic and Vascular Department, Cardiology Unit, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Heart Tower—Room 807, Largo Citta` d’Ippocrate, 84131 Salerno, Italy;; 2Neurology Department, Stroke Unit, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Largo Citta` d’Ippocrate, 84131 Salerno, Italy; and 3Vascular Pathophysiology Unit, IRCCS Neuromed, Via Atinense, 18, 86077 Pozzilli, Isernia, Italy Received 2 September 2020; first decision 22 October 2020; accepted 28 January 2021 For the podcast associated with this article, please visit https://academic.oup.com/ehjcr/pages/podcast Background Takotsubo syndrome (TTS) is an acute and transient heart failure syndrome due to reversible myocardial dysfunc- tion characterized by a wide spectrum of possible clinical scenarios. About one-fifth of TTS patients experience ad- verse in-hospital events. Thromboembolic complications, especially stroke, have been reported, albeit in a minority of patients. ................................................................................................................................................................................................... Case summary A 69-year-old woman presented to our emergency department for dyspnoea after a family quarrel. Electrocardiogram revealed ST-segment elevation in anterolateral leads and laboratory exams showed a slight ele- vation of high-sensitivity cardiac troponin. The patient was treated according to current guidelines on ST-elevation myocardial infarction and referred to the cath lab. Urgent coronary angiography revealed normal coronary arteries.
    [Show full text]
  • Heart Sound Classification for Murmur Abnormality Detection Using an Ensemble Approach Based on Traditional Classifiers and Feature Sets
    Anatolian Journal of Computer Sciences Volume:5 No:1 2020 © Anatolian Science pp:1-13 ISSN:2548-1304 Heart Sound Classification for Murmur Abnormality Detection Using an Ensemble Approach Based on Traditional Classifiers and Feature Sets Ali Fatih Gündüz1*, Ali Karcı2 *1Akçadağ Voc. Highschool, Malatya Turgut Ozal Uni., Malatya, Turkey ([email protected]) 2Department of Computer Eng., Inonu University, Malatya, Turkey, ([email protected]) Received Date: Jan. 7, 2020. Acceptance Date: Mar. 21, 2020. Published Date : Jun. 1, 2020. Abstract— Phonocardiography (PCG) is a method based on examination of mechanical sounds coming from heart during its regular contraction/relaxation activities such as opening and closing of the valves and blood turbulence towards vessels and heart chambers. Today there are high technology tools to record those sounds in electronic environment and enable us to analyze them in detail. The constraints such as human’s limited audible range, environment noise and inexperience of physicians can be overcome by the use of those tools and development of state-of-art signal processing and machine learning methods. In this study we examined heart sounds and classified them as normal or abnormal focusing on the efficiency of ensemble classifiers. Features of heart sounds are extracted by using Discrete Wavelet Transform (DWT), Mel-Frequency Cepstral Coefficients (MFCC) and time-domain morphological characteristics of the signals. As a novel contribution, Karcı entropy is derived from DWT of PCG signals and used for the first time as feature in heart sound classification. K-Nearest Neighbor (kNN), Support Vector Machine (SVM), Multilayer Perceptron (MLP) classifiers and their ensembles are used as classifiers.
    [Show full text]
  • MIT Automated Auscultation System By
    MIT Automated Auscultation System by Zeeshan Hassan Syed S.B., Computer Science and Engineering Massachusetts Institute of Technology (2003) Submitted to the Department of Electrical Engineering and Computer Science in partial fulfillment of the requirements for the degree of Master of Engineering in Electrical Engineering and Computer Science at the MASSACHUSETTS INSTITUTE OF TECHNOLOGY May 2003 @Zeeshan H. Syed, MMIII. All rights reserved. The author hereby grants to MIT permission to reproduce and publicly distribute paper and electronic copies of this thesis document in whole or in part. MASSACHUSETTS INSTiTUTE OF TECHNOLOGY JUL 2 0 2004 LIBRARIES A uthor . ...................... o lectrical Engineering and Computer Science May 9, 2003 Certified by... .. ....... John V. Guttag Professor, ComDuter Science and Engineering Thesis Supervisor Accepted by........... Arthur C. Smith Chairman, Department Uommittee on Graduate Theses BARKER 2 MIT Automated Auscultation System by Zeeshan Hassan Syed S.B., Computer Science and Engineering Massachusetts Institute of Technology (2003) Submitted to the Department of Electrical Engineering and Computer Science on May 9, 2003, in partial fulfillment of the requirements for the degree of Master of Engineering in Electrical Engineering and Computer Science Abstract At every annual exam, the primary care physician uses a stethoscope to listen for cardiac abnormalities. This approach is non-invasive, inexpensive, and fast. It is also highly unreliable. Over 80% of the people referred to cardiologists as suffering from the most commonly diagnosed condition, mitral valve prolapse (MVP), do not have this condition. Working in conjunction with cardiologists at MGH, we developed a robust, low cost, easy to use tool that can be employed to diagnose MVP in the office of pri- mary care physicians.
    [Show full text]
  • Ministry of Health of Ukraine Kharkiv National Medical University
    Ministry of Health of Ukraine Kharkiv National Medical University AUSCULTATION OF THE HEART. NORMAL HEART SOUNDS, REDUPLICATION OF THE SOUNDS, ADDITIONAL SOUNDS (TRIPLE RHYTHM, GALLOP RHYTHM), ORGANIC AND FUNCTIONAL HEART MURMURS Methodical instructions for students Рекомендовано Ученым советом ХНМУ Протокол №__от_______2017 г. Kharkiv KhNMU 2017 Auscultation of the heart. normal heart sounds, reduplication of the sounds, additional sounds (triple rhythm, gallop rhythm), organic and functional heart murmurs / Authors: Т.V. Ashcheulova, O.M. Kovalyova, O.V. Honchar. – Kharkiv: KhNMU, 2017. – 20 с. Authors: Т.V. Ashcheulova O.M. Kovalyova O.V. Honchar AUSCULTATION OF THE HEART To understand the underlying mechanisms contributing to the cardiac tones formation, it is necessary to remember the sequence of myocardial and valvular action during the cardiac cycle. During ventricular systole: 1. Asynchronous contraction, when separate areas of myocardial wall start to contract and intraventricular pressure rises. 2. Isometric contraction, when the main part of the ventricular myocardium contracts, atrioventricular valves close, and intraventricular pressure significantly increases. 3. The ejection phase, when the intraventricular pressure reaches the pressure in the main vessels, and the semilunar valves open. During diastole (ventricular relaxation): 1. Closure of semilunar valves. 2. Isometric relaxation – initial relaxation of ventricular myocardium, with atrioventricular and semilunar valves closed, until the pressure in the ventricles becomes lower than in the atria. 3. Phases of fast and slow ventricular filling - atrioventricular valves open and blood flows from the atria to the ventricles. 4. Atrial systole, after which cardiac cycle repeats again. The noise produced By a working heart is called heart sounds. In auscultation two sounds can be well heard in healthy subjects: the first sound (S1), which is produced during systole, and the second sound (S2), which occurs during diastole.
    [Show full text]
  • Accidental Heart Murmurs Doi: 10.5455/Medarh.2017.71.284-287 Edin Begic1, Zijo Begic2 MED ARCH
    REVIEW Accidental Heart Murmurs doi: 10.5455/medarh.2017.71.284-287 Edin Begic1, Zijo Begic2 MED ARCH. 2017 AUG; 71(4): 284-287 RECEIVED: JUN 20, 2017 | ACCEPTED: AUG 01, 2017 ABSTRACT Introduction: Accidental murmurs occur in anatomically and physiologically normal heart. Ac- cidental (innocent) murmurs have their own clearly defined clinical characteristics (asymp- tomatic, they require minimal follow-up care). Aim: To point out the significance of ausculta- 1Faculty of Medicine, Sarajevo School of Science and tion of the heart in the differentiation of heart murmurs and show clinical characteristics of Technology, Sarajevo, Bosnia and Herzegovina accidental heart murmurs. Material and methods: Article presents review of literature which 2Pediatric Clinic, University Clinical Center Sarajevo, deals with the issue of accidental heart murmurs in the pediatric cardiology. Results: In the Sarajevo, Bosnia and Herzegovina group of accidental murmurs we include classic vibratory parasternal-precordial Stills mur- mur, pulmonary ejection murmur, the systolic murmur of pulmonary flow in neonates, venous Corresponding author: Edin Begic, MD. Faculty of hum, carotid bruit, Potaine murmur, benign cephalic murmur and mammary souffle. Con- Medicine, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina. ORCID ID: http:// clusion: Accidental heart murmurs are revealed by auscultation in over 50% of children and www.orcid.org/0000-0001-6842-262X. E-mail: youth, with a peak occurrence between 3-6 years or 8-12 years of life. Reducing the frequency [email protected]. of murmurs in the later period can be related to poor conduction of the murmur, although the disappearance of murmur in principle is not expected.
    [Show full text]
  • 6-Heart Sounds.Pdf
    CARDIOVASCULAR SYSTEM HEART SOUNDS Dr Syed Shahid Habib MBBS DSDM PGDCR FCPS Professor & Consultant Clinical Neurophysiology Dept. of Physiology College of Medicine & KKUH King Saud University PROF. HABIB 2018 OBJECTIVES At the end of the lecture you should be able to ….. 1. Enumerate the different heart sounds 2. Describe the cause and characteristic features of first and second heart sound 3. Correlate the heart sounds with different phases of cardiac cycle 4. Define murmurs and their clinical importance PROF. HABIB 2018 HEART SOUNDS D U P L U B B L U B B Heart sounds PROF. HABIB 2018 BEST HEARD AT 4 AREAS OF AUSCULTATION AREAS: ■ Pulmonary area: • 2nd Lt intercostal space ■ Aortic area: • 2nd Rt costal cartilage ■ Mitral area: • 5nd Lt intercostal space crossing mid- clavicular line, or • 9cm (2.5-3 in) from sternum ■ Tricuspid area: • lower part of sternum towards Rt side PROF. HABIB 2018 PROF. HABIB 2018 The Events of the Cardiac Cycle HEART SOUNDS • There are four heart sounds SI, S2, S3 & S4. • Two heart sound are audible with stethoscope S1 & S2 (Lub - Dub). • S3 & S4 are not audible with stethoscope Under normal conditions because they are low frequency sounds. • Ventricular Systole is between First and second Heart sound. • Ventricular diastole is between Second and First heart sounds. PROF. HABIB 2018 FIRST HEART SOUND (S1) • It is produced due to the closure of Atrioventricular valves (Mitral & Tricuspid) • It occurs at the beginning of the systole and sounds like LUB (beginning of the ‘isometric contraction’ phase) • Frequency: 25-45 Hz • Time: 0.15 sec • Its is heavier when compared to the 2nd heart sound.
    [Show full text]
  • Hypertension Core Curriculum. Final.Indd
    MICHIGAN HYPERTENSION CORE CURRICULUM Education modules for training and updating physicians and other health professionals in hypertension detection, treatment and control Developed by the Hypertension Expert Group A Partnership of the National Kidney Foundation of Michigan and the Michigan Department of Community Health 2010 Michigan Hypertension Core Curriculum 2010 Developed by the Hypertension Expert Group A Partnership of the National Kidney Foundation of Michigan and the Michigan Department of Community Health 2 Hypertension Core Curriculum NKFM & MDCH 3 Acknowledgements Hypertension Expert Workgroup Committee April 2010 Ziad Arabi, MD, Senior Staff Physician, Internal Medicine/Hospitalist Medicine, Henry Ford Hospital, Certified Physician Specialist in Clinical Hypertension* Dear Colleague: Aaref Badshah, MD, Chief Medical Resident, Department of Internal Medicine Saint Joseph Mercy-Oakland Hospital * In 2005, the Michigan Department of Community Health (MDCH) and the National Kidney Foundation of Michigan (NKFM) convened a group of hypertension experts to identify strategies that will improve Jason I Biederman DO, FACOI FASN, Hypertension Nephrology Associates, PC* blood pressure control in Michigan. Participants included physicians from across Michigan specializing Joseph Blount, MD, MPH, FACP, Medical Director, OmniCare Health Plan, Detroit, MI in clinical hypertension, leaders in academic research of hypertension and related disorders, and Mark Britton, MD, PhD, Center of Urban and African-American Health Executive Committee, Wayne representatives of key health care organizations that are addressing this condition that afflicts over 70 State University School of medicine, Wayne State University* million U.S. adults. The Hypertension Expert Group has focused on approaches to reduce the burden of kidney and cardiovascular diseases through more effective blood pressure treatment strategies.
    [Show full text]
  • Test Questions – INTERNAL PROPEDEUTIC – 3Rd Year GM, Winter Semester 1
    Test questions – INTERNAL PROPEDEUTIC – 3rd Year GM, winter semester 1. Pain is: 49. A hard, irregular prostatic gland suggests: 2. Dyspnea is: 50. Inhealthy individual the abdominal wall is: 3. Sign is: 51. Undulation (fluid wave) test is used in the 4. Subjective feelings of the patient are: examination of: 5 .Abdominal bruit: 52. Rectal examination should be routine in the 6. An enlarged left kidney from the enlarged spleen following circumstances: may be differentiated by palpation: 53. Elevated niveau of abdomen above chest can be 7. Abdominal angina: present in: 8. Blumberg sign is positive in inflammation of 54. Jaundice, septic fever and right upper quadrant pain 9. Caput medusae is common in is a common characteristic of 10. Cullen sign: 55. Ankle-brachial index informs about: 11. Defence musculaire is 56. Diabetic foot: 12. Defense musculaire is 57. Homans’s sign: 13. Grey-Turner sign: 58. Cold and pale lower limb is typical for: 14. Deep palpation is usually not limited in: 59. Claudication pain in peripheral artery disease: 15. The upper border of the liver in midclavicular line 60. Lowenberg ́s sign: may be assessed: 61. Which arteries are not usually palpated on lower 16. Incarcerated hernia is: limbs: 17. The scar parallel to right costal margin is typical 62. Oedema of lower extremities caused by renal for diseases: 18. The respiratory movements from xiphoid to both 63. Phlegmasia coerulea dolens is sign of: inguinal regions are completely absent in: 64. Postphlebitic syndrome: 19. Which organs are projecting to right upper 65. Claudication pain of lower extremities: abdominal quadrant: 66.
    [Show full text]
  • ACCF/AHA 2011 Expert Consensus Document on Hypertension in The
    Journal of the American College of Cardiology Vol. 57, No. 20, 2011 © 2011 by the American College of Cardiology Foundation and the American Heart Association, Inc. ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.008 EXPERT CONSENSUS DOCUMENT ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension Writing Wilbert S. Aronow, MD, FACC, Co-Chair* Eduardo Ortiz, MD, MPH† Committee Jerome L. Fleg, MD, FACC, Co-Chair† Efrain Reisin, MD, FASN** Members Carl J. Pepine, MD, MACC, Co-Chair* Michael W. Rich, MD, FACC†† Douglas D. Schocken, MD, FACC, FAHA‡‡ Nancy T. Artinian, PHD, RN, FAHA‡ Michael A. Weber, MD, FACC§§ ʈʈ George Bakris, MD, FASN Deborah J. Wesley, RN, BSN Alan S. Brown, MD, FACC, FAHA‡ *American College of Cardiology Foundation Representative; †Na- Keith C. Ferdinand, MD, FACC§ tional Heart, Lung, and Blood Institute; ‡American Heart Association ʈ Representative; §Association of Black Cardiologists Representative; Mary Ann Forciea, MD, FACP ʈAmerican College of Physicians Representative; ¶American Academy William H. Frishman, MD, FACC* of Neurology Representative; #European Society of Hypertension Representative; **American Society of Nephrology Representative; Cheryl Jaigobin, MD¶ ††American Geriatrics Society Representative; ‡‡American Society for Preventive Cardiology Representative; §§American Society of Hyper- John B. Kostis, MD, FACC tension Representative; ʈʈACCF Task Force on Clinical Expert Con- Giuseppi Mancia, MD# sensus Documents Representative.
    [Show full text]
  • EPIC Change to the Management of Mitral Valve Disease
    FOCUS > COMPANION ANIMAL EPIC change to the management of mitral valve disease An EPIC change to the management of canine mitral valve disease is discussed by Jenny Wilshaw BVet- Med MRCVS, PhD Student, Royal Veterinary College, London, UK Stage Definition A Individuals in this stage have no identifiable structural valve lesions (At risk) but, based on signalment, are at risk of developing MVD B This is the asymptomatic Stage B1: No evidence of (Asymp- (preclinical) stage of MVD. Stage cardiomegaly tomatic) B is used to identify patients that have valvular disease but Stage B2: Echocardiographic do not have congestive heart and/or radiographic evidence of failure (CHF). The stage is left-sided cardiac enlargement subcategorised numerically C Patients have experienced clinical signs of CHF and require continuous medical therapy with a potent diuretic D Patients have clinical signs of CHF that are refractory to standard therapies Table 1: The American College of Veterinary Internal Medicine staging scheme for degenerative mitral valve disease. Adapted from: Atkins C, Bonagura J, Ettinger S et al. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 2009; 23: 1142-1150. ASYMPTOMATIC MVD AND THE EPIC STUDY The EPIC study was a large, prospective, blinded, randomised placebo-controlled trial that evaluated the benefit of chronic oral administration of pimobendan to dogs with stage B2 disease (see Table 1).1,2 The results of EPIC showed a significant benefit to treating these dogs with pimobendan (Vetmedin), as the risk of developing CHF or cardiac-related death was reduced by 36% for dogs in the treatment group.
    [Show full text]
  • Department of Pediatric Neurology and Pediatrics Medical University of Warsaw } from 3-5 to 12 in 1000 Live Births
    Department of Pediatric Neurology and Pediatrics Medical University of Warsaw } From 3-5 to 12 in 1000 live births } Average 10 in 1000 live births } In most cases cardiac surgery is required, usually in the first year of life } multifactorial, usually unknown } most of defects are sporadic } Higher risk of disease in children with relevant family history of cardiovascular abnormalities } Some defects are associated with chromosomal anomalies (Down syndrome) } Environmental factors acting in utero : ◦ Infections e.g.: rubella ◦ Diabetes mellitus ◦ Lupus erythematosus ◦ Alcoholism ◦ Epilepsy ◦ Some medications (e.g. hydantoin) } Case history } Physical examination } ECG } Thoracic X-ray } Echocardiography } Isotope angiography } Cardiac catheterization and angiocardiography } Examination by: ◦ Watching ◦ Palpating ◦ Percussion ◦ Ascultation } The most common abnormalities: ◦ Cyanosis ◦ Abnormal cardiac tones ◦ Heart murmurs ◦ Heart failure } 1- very silent } 2- soft, audible but silent } 3- audible, but without the thoracic tremor } 4- audible, with thoracic tremor } 5- loud, audible with stetoscope } 6- very loud, audible without the stetoscope } Heart murmurs } Abnormal respiration (tachypnea) } Cyanosis } Cardiac arrhythmias } Cardiomegaly on X-ray } Hepatomegaly, peripheral and lung oedema } Abnormal peripheral pulse } Occurs when concentration of deoxygenated haemoglobin is over 5 g% } Evaluation of oxygenation of haemoglobin based on skin colour is unreliable } More reliable assessment based on intensity of discoloration of tongue
    [Show full text]
  • ACCF/AHA 2011 Expert Consensus Document on Hypertension in The
    ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association ofBlack Cardiologists, European Society of Hypertension, Wilbert S. Aronow, Jerome L. Fleg, Carl J. Pepine, Nancy T. Artinian, George Bakris, Alan S. Brown, Keith C. Ferdinand, Mary Ann Forciea, William H. Frishman, Cheryl Jaigobin, John B. Kostis, Giuseppi Mancia, Suzanne Oparil, Eduardo Ortiz, Efrain Reisin, Michael W. Rich, Douglas D. Schocken, Michael A. Weber, and Deborah J. Wesley J. Am. Coll. Cardiol. published online Apr 25, 2011; doi:10.1016/j.jacc.2011.01.008 This information is current as of April 25, 2011 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://content.onlinejacc.org/cgi/content/full/j.jacc.2011.01.008v1 Downloaded from content.onlinejacc.org by on April 25, 2011 Journal of the American College of Cardiology Vol. 57, No. 20, 2011 © 2011 by the American College of Cardiology Foundation and the American Heart Association, Inc. ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.008 EXPERT CONSENSUS DOCUMENT ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension Writing Wilbert S.
    [Show full text]